Capricor 治療公司
US ˙ NasdaqGS ˙ US14070B3096

SecurityCAPR / Capricor Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership423,819 shares
Latest Disclosed Value $ 12,884,097
Morgan Stanley reports 27.66% decrease in ownership of CAPR / Capricor Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 423,819 shares of Capricor Therapeutics, Inc. (US:CAPR) valued at $12,884,098 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 585,840 shares of Capricor Therapeutics, Inc.. This represents a change in shares of -27.66% during the quarter. The current value of the position is $11,845,741 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 423,819 -162,021 -27.66 12,884 -23.79 0.0008
2026-05-27 2025-12-31 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 585,840 34,146 6.19 16,907 325.12 0.0010
2026-02-13 2025-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 585,840 34,146 16,907 0.0010
2026-05-27 2025-09-30 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 551,694 1,113 0.20 3,978 -27.25 0.0002
2025-11-14 2025-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 551,694 1,113 3,978 0.0002
2025-08-15 2025-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 550,581 -264,784 -32.47 5,467 -29.34 0.0004
2025-05-15 2025-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 815,365 183,611 29.06 7,738 -11.25 0.0006
2025-05-15 2024-12-31 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 631,754 500,238 380.36 8,718 335.90 0.0006
2025-02-14 2024-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 631,754 500,238 8,718 0.0006
2025-05-14 2024-09-30 13F/A-2 CAPRICOR THERAPEUTICS COM NEW 14070B309 131,516 52,321 66.07 2,000 430.50 0.0001
2025-02-14 2024-09-30 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 131,516 52,321 2,000 0.0001
2024-11-14 2024-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 131,516 52,321 2,000 0.0000
2025-05-14 2024-06-30 13F/A-2 CAPRICOR THERAPEUTICS COM NEW 14070B309 79,195 -32,402 -29.03 378 -50.20 0.0000
2024-10-17 2024-06-30 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 79,195 -32,402 378 0.0000
2024-08-14 2024-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 79,195 -32,402 378 0.0000
2024-10-17 2024-03-31 13F/A-2 CAPRICOR THERAPEUTICS COM NEW 14070B309 111,597 63,909 134.01 758 224.89 0.0001
2024-08-16 2024-03-31 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 111,597 63,909 758 0.0001
2024-05-15 2024-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 111,597 63,909 758 0.0001
2024-08-16 2023-12-31 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 47,688 5,000 11.71 233 60.69 0.0000
2024-02-13 2023-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 47,688 5,000 233 0.0000
2023-11-15 2023-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 42,688 -10,444 -19.66 146 -42.69 0.0000
2023-08-14 2023-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 53,132 10,134 23.57 254 39.78 0.0000
2023-05-15 2023-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 42,998 346 0.81 181 10.37 0.0000
2023-02-14 2022-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 42,652 2,950 7.43 165 -31.09 0.0000
2022-11-14 2022-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 39,702 1,820 4.80 238 80.30 0.0000
2022-10-27 2022-06-30 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 37,882 4,137 12.26 132 13.79 0.0000
2022-08-15 2022-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 37,882 4,137 132 0.0000
2022-10-27 2022-03-31 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 33,745 534 1.61 116 18.37 0.0000
2022-05-13 2022-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 33,745 534 116 0.0000
2022-02-14 2021-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 33,211 -17,452 -34.45 98 -51.96 0.0000
2021-11-15 2021-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 50,663 6,213 13.98 204 -10.53 0.0000
2021-08-23 2021-06-30 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 44,450 14,000 45.98 228 59.44 0.0000
2021-08-16 2021-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 44,450 14,000 228 0.0000
2021-05-17 2021-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 30,450 -25,157 -45.24 143 -25.13 0.0000
2021-02-16 2020-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 55,607 10,764 24.00 191 -18.72 0.0000
2020-11-13 2020-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 44,843 9,372 26.42 235 44.17 0.0000
2020-08-14 2020-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 35,471 33,746 1,956.29 163 8,050.00 0.0000
2020-05-26 2020-03-31 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 1,725 0 0.00 2 0.00 0.0000
2020-05-15 2020-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 1,725 0 2 0.1536
2020-02-14 2019-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 1,725 -1,691 -49.50 2 -84.62 0.0000
2019-11-14 2019-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 3,416 3,346 4,780.00 13 550.00 0.0000
2019-08-14 2019-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 70 70 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.